Skip to content

A clinical trial to find out Effectiveness of Dalbergia sissoo extract (Dalzbone capsules) in femur fracture healing.

A randomized single blind, placebo control clinical study to evaluate the efficacy of Dalbergia sissoo extract (Dalzbone capsule) in healing of diaphyseal fracture of femur - DSFFCT

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017690
Enrollment
60
Registered
2019-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S723- Fracture of shaft of femur

Interventions

Intervention1: Dal-Z-Bone capsules: Capsules of 300mg of Dalbergia sissoo leaves extract
one capsule twice a day after food for the period of six months Control Intervention1: Placebo: Capsules of 300mg of dextrin Control Intervention2: Placebo capsules: Capsules of 300mg of dextrin
One capsule twice a day after food for the period of six months.

Sponsors

Pharmanza Herbal Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Radiologically diagnosed traumatic diaphyseal fracture of femur bone indifferent of compound, comminuted, closed or open fracture with surgical intervention. 2. Willing to give informed consent. 3. 0-5 days from the incident of fracture.

Exclusion criteria

Exclusion criteria: 1. Pathological fracture. 2. Fracture patients with uncontrolled HTN(Blood Pressure >=140 mmHg or an average Diastolic Blood Pressure >=90 mmHg among those with HTN) or diabetes (Blood Glucose Level > 200 and Fasting Blood Glucose Level > 125 among those with diabetes) 3. Fracture in smokers. 4. Pregnant and breast feeding women. 5. History of allergy to herbal medicines. 6. Patient with renal failure, liver failure and or cardiac failure.

Design outcomes

Primary

MeasureTime frame
1. Restoration of functional motility confirmed by clinical assessment. 2. Radiological healing and biochemical marker analysisTimepoint: 0 week, 2 week, 6 week, 12 week, 16 week and 24 week.

Secondary

MeasureTime frame
Radiological healing and biochemical marker analysisTimepoint: 0 week, 2 week, 6 week, 12 week, 16 week and 24 week.

Countries

India

Contacts

Public ContactDr Punam Sawarkar

Mahatma Gandhi Ayurveda college hospital and Research centre

drsuple.punam@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026